Follow Our
Journey.

● SEPTEMBER 4, 2026

Core-Oli-T AB participated at Day Break 2026 on Öland

On September 4, Core-Oli-T AB participated in Day Break 2026 at VIDA Museum & Konsthall on Öland. The event brought together entrepreneurs, investors and representatives from academia for a day of inspiring conversations, pitches and new connections. For Core-Oli-T AB, Day Break provided a valuable opportunity to present our journey and engage in discussions about innovation, entrepreneurship and the development of new solutions for Parkinson’s disease. We would like to thank the organizers and everyone we met for an inspiring and rewarding day.

● JUNE 15, 2026

Core-Oli-T AB participated at the Life-Science Innovation Frontiers Forum, LSIFF at Life City Stockholm

On June 15, Core-Oli-T AB participated in this year’s Life Science Innovation Frontiers Forum (LSIFF), a meeting place for early-stage life science innovation, investors, and industry stakeholders. As a biotech company developing next-generation monoclonal antibody technologies for early Parkinson’s disease diagnostics, brain imaging, and future therapeutics, Core-Oli-T was proud to be part of a forum that highlights groundbreaking research with real potential to improve patient care and shape the future of precision medicine.

● May 7, 2026

Core-Oli-T AB Receives Grant from TillväxtKronan – Coompanion

Core-Oli-T AB has been awarded a grant of 50 000 SEK from TillväxtKronan – Coompanion for the project “Early Diagnosis and Treatment of Parkinson’s Disease”. The decision was made by TillväxtKronan’s review committee during the spring 2026 funding round following an evaluation of applications from across the region. The funding will support the company’s continued work in early diagnostics and innovative strategies for Parkinson’s disease. We are very pleased and grateful for the confidence shown by TillväxtKronan.

“The support strengthens our ability to continue developing solutions that may contribute to early detection and improved treatment for patients living Parkinson’s disease”, says Björn CG Karlsson, CEO of Core-Oli-T AB.

The project is carried out with support from TillväxtKronan and Coompanion Kalmar Län.

● january 15, 2026

MedTechMagazine – Life Science Sweden presents Core-Oli-T AB as one of the most recently established biotech companies.

● October 28, 2025

The business incubator Kalmar Science Park welcomes Core-Oli-T AB
as a new member (ONLY AVAILABLE IN SWEDISH).

● August 11, 2025

Linnaeus Venture AB reports on a new strategic partnership and investment in the innovative start up Core-Oli-T AB.

● August 7, 2025

The Linnaeus University Promotes the winners of the 2024 Linnaeus University Innovation Call on Facebook.

● March 10, 2025

Core-Oli-T AB is registered as a company.